Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069615 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children
A Phase 4 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00069615 is a Phase 4 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 15 participants.
The verdict
NCT00069615, a Phase 4 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
Devices such as the GlucoWatch G2 Biographer (GW2B), which constantly measure blood sugar levels, may improve the treatment of Type 1 diabetes mellitus in children. This study evaluated the GW2B when used by children in their homes.
Interventions
- DEVICE GlucoWatch® G2™ Biographer (GW2B)
- DEVICE Continuous Glucose Monitoring System™ (CGMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2003-02 |
| Est. Completion | 2003-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069615
The ClinicalTrials.gov registry entry for NCT00069615 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GlucoWatch® G2™ Biographer (GW2B) is the first listed.
NCT00069615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00069615 about?
NCT00069615 is a clinical study titled "Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children". Devices such as the GlucoWatch G2 Biographer (GW2B), which constantly measure blood sugar levels, may improve the treatment of Type 1 diabetes mellitus in children. This study evaluated the GW2B when used by children in their homes.
What is the current status of trial NCT00069615?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2003-02. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00069615?
The interventions under investigation include: GlucoWatch® G2™ Biographer (GW2B) (DEVICE), Continuous Glucose Monitoring System™ (CGMS) (DEVICE).
Who is sponsoring clinical trial NCT00069615?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.